Live from the NIH registry
Studies recruiting near Green Bay right now
Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Pfizer
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Bellin Memorial Hospital — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Children's Oncology Group
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: NRG Oncology
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Bionic Prosthetics & Orthotics — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
AL Amyloidosis
Phase 3
Interventional 338 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
Emplify by Bellin Health Ashwaubenon — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Baylor University
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Colorectal Cancer, Sarcopenia
N/A
Observational 300 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Myelodysplastic Syndrome
Phase 2
Interventional 54 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular
Phase 3
Interventional 750 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Children's Oncology Group
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Multiple conditions
Phase 2
Interventional 120 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Eastern Cooperative Oncology Group
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 306 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: NRG Oncology
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial
Other
N/A
Interventional 97 participants sought
Saint Vincent Hospital Cancer Center at Saint Mary's — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
Standardized Application of Feeding Evaluations Using SMART Tool
Infant and Young Child Feeding
N/A
Interventional 3,500 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Wake Forest University Health Sciences
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Lymphoma, Malignant Solid Neoplasm
Phase 3
Interventional 668 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: University of Rochester
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Vincent Hospital Cancer Center Green Bay — Green Bay, Wisconsin (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Aurora BayCare Medical Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
HSHS St. Vincent Hospital Regional Cancer Center — Green Bay, Wisconsin (1.5 mi)
· Sponsor: Bristol-Myers Squibb
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Phase 3
Interventional 398 participants sought
ThedaCare Regional Cancer Center — Appleton, Wisconsin (27.3 mi)
· Sponsor: NRG Oncology